Infinium Pharmachem Ltd (INFINIUM) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Infinium Pharmachem Ltd reported sales of ₹84 Cr, operating profit of ₹10 Cr (OPM 12%) and net profit of ₹7 Cr for the quarter ended Sep 2025. Figures in ₹ crore, consolidated where available.
INFINIUM quarterly results (₹ Cr) Metric Sep 2022 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Sales 79 61 74 83 73 84 Expenses 71 51 66 75 65 74 Operating Profit 9 10 8 8 8 10 OPM 11% 17% 11% 10% 11% 12% Other Income 1 0 1 1 1 1 Interest 1 1 1 2 2 2 Depreciation 0 1 1 2 2 2 Profit before tax 8 8 7 6 5 8 Tax 22% 24% 24% 25% 41% 22% Net Profit 6 6 5 5 3 7 EPS in Rs 5.4 4.46 3.66 3.17 2.4 3.59
INFINIUM profit & loss, annual (₹ Cr) Metric Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM Sales 71 99 114 136 156 157 Expenses 66 89 98 117 136 138 Operating Profit 5 10 16 19 19 18 OPM 7% 10% 14% 14% 12% 12% Other Income 1 1 1 2 -1 2 Interest 1 2 3 2 4 4 Depreciation 1 1 1 3 3 3 Profit before tax 4 9 13 15 12 13 Tax 28% 23% 24% 24% 32% - Net Profit 3 7 10 12 8 10 EPS in Rs 13.6 30.55 9.3 8.12 5.23 5.99 Dividend Payout 0% 0% 0% 0% 0% -
INFINIUM balance sheet (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025 Equity Capital 1 5 14 16 16 Reserves 12 17 45 94 99 Borrowings 23 29 11 52 0 Other Liabilities 23 19 15 37 75 Total Liabilities 59 71 85 198 190 Fixed Assets 4 19 20 24 24 CWIP 8 0 0 1 5 Investments 0 0 0 29 29 Other Assets 46 52 66 144 132 Total Assets 59 71 85 198 190
INFINIUM cash flows (₹ Cr) Metric Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Cash from Operating Activity 7 12 9 -13 -29 Cash from Investing Activity -5 -7 -5 -4 -27 Cash from Financing Activity -1 -2 -3 23 79 Net Cash Flow 1 3 1 6 23 Free Cash Flow 2 7 1 -17 -38 CFO/OP 168% 137% 73% -51% -131%
INFINIUM ratios Metric Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Debtor Days 59 57 49 55 79 Inventory Days 62 78 89 87 137 Days Payable 79 56 31 16 38 Cash Conversion Cycle 43 78 108 126 178 Working Capital Days 12 25 27 96 97 ROCE 32% 38% 36% 28% 15%